{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:49:45Z","timestamp":1792439385335,"version":"4.5.0"},"reference-count":18,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T00:00:00Z","timestamp":1274832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:<\/jats:bold>\n                    To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse\u2010controlled release (DCR) in patients with obesity.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    This was a randomized, double\u2010blind, placebo\u2010controlled trial of 12 weeks of treatment with phentermine DCR 30 mg (n = 37) or placebo (n = 37), administered once daily in patients with obesity with controlled diabetes, hypertension or dyslipidaemia. The efficacy was evaluated by changes in body weight and waist circumference from baseline at 12 weeks and also changes in metabolic parameters, including lipid profiles and blood pressure.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    The participants in the phentermine DCR group showed significant reductions in body weight (\u22128.1 \u00b1 3.9 vs. \u22121.7 \u00b1 2.9 kg, p &lt; 0.001) and waist circumference (7.2 \u00b1 0.5 vs. 2.1 \u00b1 0.6 cm, p &lt; 0.001) compared with those in the placebo group. Weight reductions of 5% or greater from the baseline (95.8 vs. 20.8%, p &lt; 0.001) and 10% or more (62.5 vs. 4.7%, p &lt; 0.001) were achieved in the DCR phentermine group and placebo group, respectively. Total cholesterol and low\u2010density lipoprotein cholesterol (LDL\u2010C) levels were significantly improved in the phentermine DCR group. However, there were no significant differences in systolic and diastolic blood pressure between the groups. Dry mouth and insomnia were the most common adverse events, but these were mild to moderate and transient.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Short\u2010term phentermine DCR treatment resulted in significant reduction in weight and improvement of metabolic parameters, including waist circumference and some lipid profiles, without clinically severe adverse events. Further study is needed to show long\u2010term efficacy and safety of phentermine DCR in Korean patients with obesity.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2010.01242.x","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T01:28:42Z","timestamp":1274923722000},"page":"876-882","source":"Crossref","is-referenced-by-count":106,"title":["Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse\u2010controlled release for obesity"],"prefix":"10.1111","volume":"12","author":[{"given":"J. G.","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.\u2010Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.\u2010W.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. W.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,29]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2007.00421.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0520"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054017"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.7.898"},{"key":"e_1_2_7_6_2","first-page":"S5","article-title":"The beneficial effect of modest weight loss on cardiovascular risk factors","volume":"21","author":"Van Gaal LF","year":"1997","journal-title":"Int J Obes"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archinte.1984.00350180055008","article-title":"A double\u2010blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.","volume":"144","author":"Weintraub M","year":"1984","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.9.1046"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults","volume":"288","author":"Flegal KM","year":"2002","journal-title":"JAMA"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801889"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2006.04.013"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5588.352"},{"key":"e_1_2_7_13_2","first-page":"289","article-title":"A double\u2010blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity.","volume":"16","author":"Langlois KJ","year":"1974","journal-title":"Curr Ther Res"},{"key":"e_1_2_7_14_2","first-page":"300","article-title":"A comparative study of phentermine and diethylpropion in the treatment of obese patients in general practice","volume":"3","author":"Valle\u2010Jones JC","year":"1983","journal-title":"Pharmatherapeutica"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050598"},{"key":"e_1_2_7_16_2","first-page":"155","article-title":"Double\u2010blind, Parallel\u2010group, Placebo\u2010controlled Multi\u2010center Clinical Trial for Evaluating the Efficacy and Safety of Phentermine Hydrochloride in Obese Patients.","volume":"14","author":"Choi CJ","year":"2005","journal-title":"The Korean Journal of Obesity"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2006.47.5.614"},{"key":"e_1_2_7_18_2","first-page":"1","article-title":"Efficacy and Safety of Phentermine for Obese Patients: A Preliminary Open\u2010Label Study.","volume":"14","author":"Park YW.","year":"2005","journal-title":"The Korean Journal of Obesity"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-7-200504050-00012"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2010.01242.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2010.01242.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:22:46Z","timestamp":1761880966000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2010.01242.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,29]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1463-1326.2010.01242.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2010.01242.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,29]]}}}